Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma.

Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...

7 asthma medications: A guide to learn more Asthma is a chronic respiratory condition that affects millions of people of all ages. While there is no cure, modern asthma medications make it possible ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...

Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The corresponding study was published in The Lancet Respiratory Medicine. “In this ...

People with severe asthma sometimes rely on daily steroid pills, which raise the risk of diabetes, infections and bone problems. Now, a study supports the idea that a monthly antibody injection is a ...

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...

Patients who take omalizumab prior to starting oral immunotherapy (OIT) may skip much of the latter treatment’s onerous dose escalation process, according to a new study presented at the American ...